Literature DB >> 7800361

Increased serum levels of eosinophil cationic protein and eosinophil-derived neurotoxin (protein X) in vernal keratoconjunctivitis.

M Tomassini1, L Magrini, S Bonini, A Lambiase, S Bonini.   

Abstract

PURPOSE: To evaluate whether the eosinophil preformed mediators, eosinophil cationic protein X, and eosinophil-derived neurotoxin/eosinophil protein X (EDN/EPX) are detectable in serum and can be used as markers of eosinophilic inflammation.
METHODS: A competitive radioimmunoassay was used to detect serum levels of eosinophil cationic protein and EDN/EPX in 31 patients with vernal keratoconjunctivitis (VKC) and in 15 healthy controls.
RESULTS: Mean serum levels of both eosinophil cationic protein and EDN/EPX were significantly higher in patients with VKC than in controls. There was a good correlation between serum levels of eosinophil cationic protein and EDN/EPX. No significant difference in mean serum eosinophil cationic protein levels was observed between patients with positive radioallergosorbent test (RAST) results and those with negative RAST results who have VKC, whereas mean EDN/EPX and total immunoglobulin E serum levels were significantly higher in patients with positive RAST results than in those with negative RAST results who have VKC. Serum eosinophil cationic protein, but not EDN/EPX, levels were significantly related to total immunoglobulin E levels.
CONCLUSION: The authors' data indicate that serum levels of eosinophil cationic protein and EDN/EPX are useful markers of eosinophilic ocular inflammation in VKC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7800361     DOI: 10.1016/s0161-6420(94)31097-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.

Authors:  A Leonardi; F Borghesan; A Avarello; M Plebani; A G Secchi
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

2.  Eosinophil cationic protein in tears in allergic conjunctivitis.

Authors:  P G Montan; M van Hage-Hamsten
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

3.  Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitis.

Authors:  Tais Hitomi Wakamatsu; Mari Tanaka; Yoshiyuki Satake; Murat Dogru; Kazumi Fukagawa; Ayako Igarashi; Hiroshi Fujishima
Journal:  Mol Vis       Date:  2011-04-13       Impact factor: 2.367

Review 4.  A Review of Emerging Tear Proteomics Research on the Ocular Surface in Ocular Allergy.

Authors:  Esrin Aydin; Poshmaal Dhar; Moneisha Gokhale; Luke Chong; Serap Azizoglu; Cenk Suphioglu
Journal:  Biology (Basel)       Date:  2022-02-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.